Interview with The Life Sciences Division’s executive director Dr Navid Malik – 5th June 2019
6th June 2019 - 11:39 amThe Life Sciences Division’s executive director Dr Navid Malik offers up his thoughts and outlook on ImmuPharma PLC (LON:IMM) and its flagship drug Lupuzor – a treatment for the autoimmune disease Lupus.